Simian Immunodeficiency Virus-Infected Macaques Treated with Highly Active Antiretroviral Therapy Have Reduced Central Nervous System Viral Replication and Inflammation but Persistence of Viral DNAZINK, M. Christine; BRICE, Angela K; GRAHAM, David R et al.The Journal of infectious diseases. 2010, Vol 202, Num 1, pp 161-170, issn 0022-1899, 10 p.Article

Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trialHAO WANG; ROMANO, Gary; THIPPHAWONG, John et al.Neurology. 2014, Vol 83, Num 7, pp 628-637, issn 0028-3878, 10 p.Article

Low-dose Inhaled nitric oxide in Patients with acute lung injury: A randomized controlled trialTAYLOR, Robert W; ZIMMERMAN, Janice L; DELLINGER, R. Phillip et al.JAMA, the journal of the American Medical Association. 2004, Vol 291, Num 13, pp 1603-1609, issn 0098-7484, 7 p.Article

Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaquesKELLY, Kathleen M; TARWATER, Patrick M; KARPER, Jami M et al.AIDS (London). 2012, Vol 26, Num 7, pp 815-823, issn 0269-9370, 9 p.Article

Improved Survival of Critically III Trauma Patients Treated With Recombinant Human Erythropoietin. DiscussionNAPOLITANO, Lena M; FABIAN, Timothy C; MULLINS, Richard J et al.The Journal of trauma, injury, infection, and critical care. 2008, Vol 65, Num 2, pp 285-299, issn 1079-6061, 15 p.Conference Paper

Critical care delivery in the intensive care unit: Defining clinical roles and the best practice modelBRILLI, Richard J; SPEVETZ, Antoinette; ANDRE, Arthur C. St et al.Critical care medicine. 2001, Vol 29, Num 10, pp 2007-2019, issn 0090-3493Article

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis painSANGA, Panna; KATZ, Nathaniel; POLVEREJAN, Elena et al.Pain (Amsterdam). 2013, Vol 154, Num 10, pp 1910-1919, issn 0304-3959, 10 p.Article

Efficacy of Multidisciplinary Outpatient Management (MOM) Program in Long Term Heart Failure CareJAIN, Rahul; EVENSON, Ariana; JAIN, Rohit et al.Southern medical journal (Birmingham, Ala. Print). 2010, Vol 103, Num 2, pp 131-137, issn 0038-4348, 7 p.Article

HIV and SIV Induce Alterations in CNS CaMKII Expression and Activation: A Potential Mechanism for Cognitive ImpairmentGUPTA, Ravi G; KELLY, Kathleen M; MANKOWSKI, Joseph L et al.The American journal of pathology. 2010, Vol 176, Num 6, pp 2776-2784, issn 0002-9440, 9 p.Article

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brainKELLY, Kathleen M; BECK, Sarah E; METCALF PATE, Kelly A et al.AIDS (London). 2013, Vol 27, Num 18, issn 0269-9370, F21-F28Article

Replication-Competent Simian Immunodeficiency Virus (SIV) Gag Escape Mutations Archived in Latent Reservoirs during Antiretroviral Treatment of SIV-Infected MacaquesQUEEN, Suzanne E; MEARS, Brian M; KENT, Stephen J et al.Journal of virology. 2011, Vol 85, Num 17, pp 9167-9175, issn 0022-538X, 9 p.Article

Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responsesGRAHAM, David R; GAMA, Lucio; QUEEN, Suzanne E et al.Journal of neurovirology. 2011, Vol 17, Num 1, pp 120-130, issn 1355-0284, 11 p.Article

Transfusion practice and blood stream infections in critically III patientsSHORR, Andrew F; JACKSON, William L; KELLY, Kathleen M et al.Chest. 2005, Vol 127, Num 5, pp 1722-1728, issn 0012-3692, 7 p.Article

Red blood cell transfusion and ventilator-associated pneumonia: A potential link?SHORR, Andrew F; DUH, Mei-Sheng; KELLY, Kathleen M et al.Critical care medicine. 2004, Vol 32, Num 3, pp 666-674, issn 0090-3493, 9 p.Article